Morphological, Structural and Functional Neural Substrates of Quality of Life in Schizophrenia

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01295411

Enrollment

100

Registered

2011-02-14

Start date

2011-01-31

Completion date

2015-09-30

Last updated

2015-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Brief summary

The aim of the investigators analysis is to identify the neural correlates of quality of life scores in schizophrenia. For this, the investigators will constitute group of patients according to their quality of life scores and the investigators will analyze their differences in patterns of brain structures and activations.

Interventions

DEVICEMagnetic Resonance Imaging

OTHEREVALUATION NEUROPSYCHOLOGICAL

Study design

Allocation

Intervention model

SINGLE_GROUP

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 40 Years

Healthy volunteers

Inclusion criteria

* diagnosis of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria (American Psychiatric Association(APA), 1994), * age over 18 years, * informed consent to participate in the studies * French as native language

Exclusion criteria

* diagnosis other than schizophrenia on Axis I of DSM-IV, * decompensated organic disease and mental retardation

Design outcomes

Primary

Measure	Time frame
to study the relationships between quality of life and the morphologic, structural and functional substrates in schizophrenia	36 months

Secondary

Measure	Time frame
to determine whether quality of life is correlated with brain modifications using functional Magnetic Resonance Imaging	36 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026